12 April 2021
Assura plc
Scrip Dividend Declaration
Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that, pursuant to its Scrip Dividend Scheme and in response to the scrip dividend alternative for the quarterly interim dividend payable on 14 April 2021 (the "Scrip Dividend Alternative"), elections were received in respect of 12 per cent. of the Company's ordinary shares in issue as at the record date of 12 March 2021.
Electing shareholders will receive ordinary shares in the Company ("Shares") in lieu of cash in respect of this dividend and, accordingly 3,011,418 Shares (the "New Shares") will be issued by the Company to such shareholders.
Application has therefore been made for the admission of the New Shares to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange's market for listed securities ("Admission"). The New Shares will rank pari passu with the Company's existing ordinary shares and Admission is expected to occur at 8.00am on 14 April 2021.
Following the allotment of the New Shares, it is expected that the total number of shares in issue will be 2,675,547,484 (none of which will be held in treasury) and that, accordingly, the total number of voting rights of the Company will be 2,675,547,484.
Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (https://data.fca.org.uk/#/nsm/nationalstoragemechanism).
This interim dividend is 100% Property Income Distribution ("PID").
Forms to register for gross PIDs (on future interim dividends) are available on the Company's website. Please click here for PID Forms.
- ENDS -
For more information, please contact:
|
Assura plc |
Tel: 01925 420680 |
| Orla Ball, Company Secretary David Purcell, Head of Investor Relations
| Email: Investor@assura.co.uk |
| Finsbury Gordon Simpson | Tel: 0207 251 3801 Email: Assura@Finsbury.com |
Notes to Editors
Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real Estate Association
Assura plc LEI code: 21380026T19N2Y52XF72
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
